feed,title,long_url,short_url
ArXiv,"A Reanalysis of the FDA's Benefit-Risk Assessment of Moderna's mRNA-1273 COVID Vaccine: For 18-25-Year-Old Males, Risks Exceeded Benefits Relative to Hospitalizations",https://arxiv.org/abs/2410.11811,
